[HTML][HTML] The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges

S Xie, Z Wu, Y Qi, B Wu, X Zhu - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Lung cancer is one of the common malignant tumors that threaten human life with serious
incidence and high mortality. According to the histopathological characteristics, lung cancer …

In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS® 9, against A549 human lung adenocarcinoma cells

KR Paudel, R Rajput, G De Rubis, VSRR Allam… - … -Research and Practice, 2023 - Elsevier
Purpose Non-small cell lung cancer (NSCLC) is among the leading causes of morbidity and
mortality worldwide. Despite the availability of several treatment options, the five-year …

Relationship between lung carcinogenesis and chronic inflammation in rodents

Y Nakano-Narusawa, M Yokohira, K Yamakawa, J Ye… - Cancers, 2021 - mdpi.com
Simple Summary Lung cancer is the most common cause of cancer-related deaths
worldwide. There are various risk factors for lung cancer, including tobacco smoking …

[HTML][HTML] Optoplasmonic biosensor for lung cancer telediagnosis: Design and simulation analysis

AG Kumela, AB Gemta, AK Hordofa, TA Desta… - Sensors …, 2023 - Elsevier
Applying quantum technology to dispatch face-to-face medical activities has generated
significant interest. Unfortunately, the work on remote medical treatment soliciting quantum …

[HTML][HTML] Non-invasive detection of orthotopic human lung tumors by microRNA expression profiling of mouse exhaled breath condensates and exhaled extracellular …

MI Mitchell, IZ Ben-Dov, C Liu, T Wang… - Extracellular vesicles …, 2024 - ncbi.nlm.nih.gov
Aim: The lung is the second most frequent site of metastatic dissemination. Early detection is
key to improving survival. Given that the lung interfaces with the external environment, the …

[HTML][HTML] Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment

FPM Rowdo, G Xiao, GF Khramtsova, J Nguyen… - Cancer Letters, 2024 - Elsevier
Poly (ADP-ribose) polymerase inhibitors (PARPi) are used for patients with BRCA1/2
mutations, but patients with other mutations may benefit from PARPi treatment. Another …

How to improve sbrt outcomes in nsclc: From pre-clinical modeling to successful clinical translation

M Milic, M Mondini, E Deutsch - Cancers, 2022 - mdpi.com
Simple Summary Despite major research and clinical efforts, lung cancer remains the
leading cause of cancer-related death. Stereotactic body radiotherapy (SBRT) has emerged …

A study on metabolic characteristics and metabolic markers of gastrointestinal tumors

S Cong, shanshan Bai, M Zhang… - Cancer Biology & …, 2023 - Taylor & Francis
Tumor cells have significant heterogeneity in metabolism and are closely related to
prognosis, gene mutation, and subtype. However, this association has not been …

Advanced therapies for precision medicine in oncology

MA Mimoso - 2022 - repositorio.ul.pt
Cancer is a worldwide problem, and despite tremendous advances in science and medicine
in the understanding of its biology and genetics, it is still a major cause of death. For a long …

[PDF][PDF] Sensors International

AG Kumela, AB Gemta, AK Hordofa, TA Desta… - researchgate.net
Applying quantum technology to dispatch face-to-face medical activities has generated
significant interest. Unfortunately, the work on remote medical treatment soliciting quantum …